Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury

---

Atıf İçin Kopyala

DEMİR K., KUMRAL A., DUMAN N., SARIOĞLU S., Yilmaz O., Yesilirmak D. C., ...Daha Fazla

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.21, sa.6, ss.407-413, 2008 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 21 Sayı: 6
• Basım Tarihi: 2008
• Doi Numarası: 10.1080/14767050802045715
• Dergi Adı: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.407-413
• Anahtar Kelimeler: hyperoxic lung injury, bronchopulmonary dysplasia, newborn, clarithromycin, montelukast, pentoxifylline, PULMONARY EPITHELIAL-CELLS, BRONCHOPULMONARY DYSPLASIA, NEWBORN RAT, EXPRESSION, INFANTS, ALVEOLARIZATION, ERYTHROMYCIN, MACROLIDES, APOPTOSIS, CYTOKINES
• Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. We aimed to assess the efficiency of clarithromycin, montelukast, and pentoxifylline treatments, alone and in combination, in reducing hyperoxic lung injury at the histopathologic level.